Skip to main content
. 2020 Mar 10;15(3):e0229850. doi: 10.1371/journal.pone.0229850

Fig 4. Prolonged Aβ40 reduction in plasma and CSF after repeated dosing.

Fig 4

(A and B) Pharmacokinetic parameters observed in (A) blood (red circles) and (B) CSF (blue squares) after repeated 10mg/kg i.v. injections (arrows) of sFab OX26-NEP in cisterna magna cannulated rats (N = 3). (C and D) Aβ40 levels measured in (C) blood plasma (red circles) and (D) CSF (blue squares).